Atlas Trials

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Clinical trial NCT04580771 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04580771
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IB3 Cervical Cancer FIGO 2018Stage II Cervical Cancer FIGO 2018Stage IIA Cervical Cancer FIGO 2018Stage IIA1 Cervical Cancer FIGO 2018Stage IIA2 Cervical Cancer FIGO 2018Stage IIB Cervical Cancer FIGO 2018Stage III Cervical Cancer FIGO 2018Stage IIIA Cervical Cancer FIGO 2018Stage IIIB Cervical Cancer FIGO 2018Stage IIIC Cervical Cancer FIGO 2018Stage IIIC1 Cervical Cancer FIGO 2018
Start date
2020-10-14
Primary completion
2027-03-08
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.